In contrast, administration of leptin for 2 weeks to patients with obesity and newly diagnosed type 2 diabetes had no effect on either fat mass or any measure of glucose metabolism or insulin sensitivity (64). This evidence concerns the gene LEP and type 2 diabetes mellitus.